Bristol Myers EVP exercises awards, gets new grants
Bristol Myers Squibb executive Karin Shanahan reported multiple equity compensation transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Bristol Myers Squibb executive Karin Shanahan reported multiple equity compensation transactions. On March 10, 2026, she exercised or converted derivative awards into 25,501 shares of common stock and received new grants of 21,224 market share units and 31,837 performance shares.
The filing shows 7,760 shares of common stock were withheld at $60.13 per share to cover tax obligations upon vesting. After these routine compensation-related events and adjustments, Shanahan directly held 24,273 shares of common stock and indirectly held 1,278.64 shares through the BMS Savings and Investment Program.
Insider Trade Summary
25,501 shares exercised/converted
Exercise
15 txns
Insider
Shanahan Karin
Role
EVP, Chief Supply Chain & Ops
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Market Share Units | 2,448 | $0.00 | $0.00 |
| Exercise | Market Share Units | 3,293 | $0.00 | $0.00 |
| Exercise | Performance Shares | 19,760 | $0.00 | $0.00 |
| Grant/Award | Market Share Units | 21,224 | $0.00 | $0.00 |
| Grant/Award | Performance Shares | 31,837 | $0.00 | $0.00 |
| Exercise | Common Stock, $0.10 par value | 2,448 | $0.00 | $0.00 |
| Other | Common Stock, $0.10 par value | 275 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock, $0.10 par value | 1,112 | $60.13 | $67K |
| Exercise | Common Stock, $0.10 par value | 3,293 | $0.00 | $0.00 |
| Other | Common Stock, $0.10 par value | 356 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock, $0.10 par value | 1,503 | $60.13 | $90K |
| Exercise | Common Stock, $0.10 par value | 19,760 | $0.00 | $0.00 |
| Other | Common Stock, $0.10 par value | 9,702 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock, $0.10 par value | 5,145 | $60.13 | $309K |
| holding | Common Stock, $0.10 par value | -- | -- | -- |
Holdings After Transaction:
Market Share Units — 24,518 contracts (Direct);
Performance Shares — 31,837 contracts (Direct);
Common Stock, $0.10 par value — 24,273 shares (Direct);
Common Stock, $0.10 par value — 1,278.64 shares (Indirect, BMS Savings and Investment Program)
Footnotes (12)
- F1. Represents vesting of one-quarter of market share units granted on March 10, 2022.
- F2. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
- F3. Shares withheld for payment of taxes upon vesting of awards.
- F4. Represents vesting of one-quarter of market share units granted on March 10, 2023.
- F5. Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award.
- F6. Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board.
- F7. Based on recent 401(k) plan statement.
- F8. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
- F9. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026.
- F10. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout.
- F11. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board.
- F12. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did BMY executive Karin Shanahan report on March 10, 2026?
Karin Shanahan reported multiple equity compensation transactions on March 10, 2026. She exercised or converted derivative awards into 25,501 common shares, received new grants of market share units and performance shares, and had shares withheld to satisfy tax obligations linked to vesting.
What new equity awards did Karin Shanahan receive from Bristol Myers (BMY)?
She received 21,224 market share units and 31,837 performance shares. The market share units and performance shares are long-term incentives, generally converting into common stock in future years based on performance factors and Board certification of results under the company’s award terms.
What are Karin Shanahan’s Bristol Myers (BMY) holdings after these transactions?
After the transactions, Shanahan directly held 24,273 BMY common shares. She also indirectly held 1,278.64 additional shares through the BMS Savings and Investment Program, as reported based on a recent 401(k) plan statement referenced in the filing footnotes.
Are the BMY Form 4 transactions for Karin Shanahan open-market buys or sells?
The reported transactions are mainly award exercises, vesting, grants, and tax withholding. There are no open-market purchase or sale codes; activity consists of derivative exercises (M), grants (A), tax-withholding dispositions (F), and other award-related adjustments (J).
AI-generated analysis. How Rhea-AI works. Not financial advice.
